Revvity ROE 2010-2024 | RVTY
Current and historical return on equity (ROE) values for Revvity (RVTY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Revvity ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $0.25B | $7.92B | 3.22% |
| 2024-06-30 | $0.17B | $7.87B | 2.16% |
| 2024-03-31 | $0.15B | $7.85B | 1.92% |
| 2023-12-31 | $0.69B | $7.87B | 8.81% |
| 2023-09-30 | $0.74B | $7.69B | 9.58% |
| 2023-06-30 | $0.82B | $7.87B | 10.78% |
| 2023-03-31 | $0.96B | $8.03B | 12.97% |
| 2022-12-31 | $0.57B | $7.38B | 7.90% |
| 2022-09-30 | $0.63B | $7.07B | 8.84% |
| 2022-06-30 | $0.67B | $7.17B | 9.48% |
| 2022-03-31 | $0.74B | $7.19B | 11.61% |
| 2021-12-31 | $0.94B | $7.14B | 16.88% |
| 2021-09-30 | $1.13B | $6.96B | 23.93% |
| 2021-06-30 | $1.18B | $4.24B | 31.09% |
| 2021-03-31 | $1.07B | $4.00B | 30.80% |
| 2020-12-31 | $0.73B | $3.74B | 22.94% |
| 2020-09-30 | $0.41B | $3.23B | 14.03% |
| 2020-06-30 | $0.30B | $2.97B | 10.49% |
| 2020-03-31 | $0.23B | $2.76B | 8.26% |
| 2019-12-31 | $0.23B | $2.81B | 8.39% |
| 2019-09-30 | $0.23B | $2.71B | 8.80% |
| 2019-06-30 | $0.25B | $2.71B | 9.60% |
| 2019-03-31 | $0.25B | $2.64B | 9.58% |
| 2018-12-31 | $0.24B | $2.59B | 9.31% |
| 2018-09-30 | $0.13B | $2.57B | 4.97% |
| 2018-06-30 | $0.14B | $2.52B | 5.54% |
| 2018-03-31 | $0.28B | $2.56B | 11.16% |
| 2017-12-31 | $0.29B | $2.50B | 12.10% |
| 2017-09-30 | $0.40B | $2.54B | 17.09% |
| 2017-06-30 | $0.37B | $2.44B | 16.38% |
| 2017-03-31 | $0.23B | $2.21B | 10.53% |
| 2016-12-31 | $0.23B | $2.15B | 11.11% |
| 2016-09-30 | $0.24B | $2.14B | 11.31% |
| 2016-06-30 | $0.23B | $2.09B | 11.28% |
| 2016-03-31 | $0.22B | $2.05B | 10.51% |
| 2015-12-31 | $0.21B | $2.11B | 10.16% |
| 2015-09-30 | $0.18B | $2.05B | 8.46% |
| 2015-06-30 | $0.16B | $2.12B | 7.82% |
| 2015-03-31 | $0.16B | $2.06B | 7.93% |
| 2014-12-31 | $0.16B | $2.04B | 7.67% |
| 2014-09-30 | $0.19B | $2.06B | 9.48% |
| 2014-06-30 | $0.19B | $2.06B | 9.55% |
| 2014-03-31 | $0.17B | $2.03B | 8.66% |
| 2013-12-31 | $0.17B | $1.99B | 8.78% |
| 2013-09-30 | $0.08B | $1.92B | 4.45% |
| 2013-06-30 | $0.07B | $1.86B | 3.91% |
| 2013-03-31 | $0.08B | $1.83B | 4.21% |
| 2012-12-31 | $0.07B | $1.94B | 3.71% |
| 2012-09-30 | $0.00B | $1.94B | 0.16% |
| 2012-06-30 | $0.01B | $1.89B | 0.53% |
| 2012-03-31 | $0.01B | $1.88B | 0.31% |
| 2011-12-31 | $0.01B | $1.84B | 0.42% |
| 2011-09-30 | $0.39B | $1.95B | 20.07% |
| 2011-06-30 | $0.36B | $1.96B | 19.42% |
| 2011-03-31 | $0.39B | $1.91B | 21.83% |
| 2010-12-31 | $0.39B | $1.93B | 22.64% |
| 2010-09-30 | $0.13B | $1.71B | 7.93% |
| 2010-06-30 | $0.13B | $1.64B | 8.12% |
| 2010-03-31 | $0.10B | $1.63B | 5.97% |
| 2009-12-31 | $0.08B | $1.63B | 5.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.376B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $91.424B | 11.34 |
| Cencora (COR) | United States | $47.484B | 17.51 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Natera (NTRA) | United States | $21.401B | 0.00 |
| ICON (ICLR) | Ireland | $16.136B | 14.37 |
| Viatris (VTRS) | United States | $15.576B | 4.80 |
| Avantor (AVTR) | United States | $13.422B | 20.12 |
| CochLear (CHEOY) | Australia | $12.844B | 0.00 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| Solventum (SOLV) | United States | $11.583B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.789B | 27.58 |
| Doximity (DOCS) | United States | $9.620B | 56.63 |
| Charles River Laboratories (CRL) | United States | $9.516B | 18.39 |
| HealthEquity (HQY) | United States | $8.966B | 48.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.758B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.885B | 32.05 |
| Life Times (LTH) | United States | $5.085B | 33.66 |
| Sotera Health (SHC) | United States | $3.855B | 20.62 |
| Organon (OGN) | United States | $3.757B | 3.79 |
| BrightSpring Health Services (BTSG) | United States | $3.247B | 69.07 |
| Surgery Partners (SGRY) | United States | $2.892B | 32.97 |
| PACS (PACS) | United States | $2.606B | 0.00 |
| Concentras Parent (CON) | United States | $2.581B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.375B | 0.00 |
| Premier (PINC) | United States | $2.143B | 11.15 |
| Alignment Healthcare (ALHC) | United States | $2.126B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.952B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.616B | 42.40 |
| Teladoc Health (TDOC) | United States | $1.537B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.255B | 12.28 |
| CareDx (CDNA) | United States | $1.183B | 0.00 |
| Progyny (PGNY) | United States | $1.164B | 23.57 |
| Establishment Labs Holdings (ESTA) | $1.050B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.954B | 6.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Embecta (EMBC) | United States | $0.778B | 5.18 |
| SBC Medicals (SBC) | United States | $0.677B | 0.00 |
| Agilon Health (AGL) | United States | $0.655B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.647B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.536B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.425B | 0.00 |
| DocGo (DCGO) | United States | $0.410B | 15.46 |
| Enhabit (EHAB) | United States | $0.366B | 31.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| ModivCare (MODV) | United States | $0.223B | 12.09 |
| Sera Prognostics (SERA) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| Nutex Health (NUTX) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.25 |
| MultiPlan (MPLN) | United States | $0.084B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.043B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.08 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
| Oncology Institute (TOI) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |